Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,204 | 365 | 99.3% |
| Education | $37.13 | 4 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $819.06 | 66 | $0 (2024) |
| PFIZER INC. | $660.15 | 59 | $0 (2024) |
| Novo Nordisk Inc | $504.27 | 35 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $421.75 | 34 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $379.32 | 26 | $0 (2022) |
| ABBVIE INC. | $351.24 | 19 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $293.88 | 20 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $215.81 | 17 | $0 (2022) |
| Merck Sharp & Dohme LLC | $161.26 | 11 | $0 (2024) |
| Boston Scientific Corporation | $149.96 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $320.12 | 19 | GlaxoSmithKline, LLC. ($71.27) |
| 2023 | $626.25 | 28 | Boston Scientific Corporation ($149.96) |
| 2022 | $413.06 | 26 | ABBVIE INC. ($97.42) |
| 2021 | $686.13 | 43 | AbbVie Inc. ($111.79) |
| 2020 | $309.76 | 22 | GlaxoSmithKline, LLC. ($48.73) |
| 2019 | $816.42 | 55 | PFIZER INC. ($190.43) |
| 2018 | $965.02 | 84 | GlaxoSmithKline, LLC. ($199.32) |
| 2017 | $1,105 | 92 | GlaxoSmithKline, LLC. ($270.06) |
All Payment Transactions
369 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: VACCINES | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.03 | General |
| 10/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/23/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), PEDIARIX | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: VACCINES | ||||||
| 08/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: VACCINE | ||||||
| 07/19/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Diabetes Care | ||||||
| 07/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: Obesity | ||||||
| 07/09/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: PAIN | ||||||
| 06/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: RESPIRATORY | ||||||
| 05/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: DIABETES | ||||||
| 04/19/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: VACCINES | ||||||
| 04/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Cardio-renal | ||||||
| 03/25/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: Cardiology | ||||||
| 03/13/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: VACCINE | ||||||
| 02/07/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Diabetes Care | ||||||
| 01/12/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: VACCINES | ||||||
| 01/09/2024 | Seqirus USA Inc | Flucelvax (Biological), Fluad | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Vaccines | ||||||
| 12/06/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: VACCINES | ||||||
| 12/04/2023 | Merck Sharp & Dohme LLC | GARDASIL 9 (Biological) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: VACCINE | ||||||
| 10/30/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: PAIN | ||||||
| 10/17/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/12/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: RESPIRATORY | ||||||
| 09/21/2023 | PFIZER INC. | PREVNAR 20 (Biological), ABRYSVO | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 2,262 | 3,497 | $300,026 | $215,364 |
| 2022 | 31 | 2,578 | 4,002 | $328,947 | $240,466 |
| 2021 | 32 | 3,234 | 4,776 | $345,579 | $241,513 |
| 2020 | 20 | 2,283 | 3,985 | $269,330 | $185,015 |
All Medicare Procedures & Services
113 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 436 | 587 | $78,641 | $48,693 | 61.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 276 | 276 | $37,042 | $35,306 | 95.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 157 | 722 | $46,959 | $33,245 | 70.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 356 | 518 | $48,779 | $27,618 | 56.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 166 | 170 | $12,257 | $11,926 | 97.3% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 110 | 266 | $13,082 | $9,812 | 75.0% |
| 90671 | Pneumococcal conjugate vaccine, 15 valent (pcv15), for intramuscular use | Office | 2023 | 37 | 37 | $9,694 | $8,927 | 92.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 171 | 175 | $5,196 | $5,065 | 97.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 27 | 27 | $4,646 | $4,418 | 95.1% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 29 | 29 | $4,002 | $3,922 | 98.0% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 23 | 24 | $5,083 | $3,714 | 73.1% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 26 | 30 | $4,078 | $3,142 | 77.0% |
| 99489 | Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 26 | 51 | $3,653 | $2,828 | 77.4% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 61 | 61 | $2,339 | $2,292 | 98.0% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 16 | 16 | $2,445 | $2,093 | 85.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 14 | $2,605 | $1,841 | 70.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 37 | 42 | $2,932 | $1,705 | 58.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 53 | 53 | $1,629 | $1,596 | 98.0% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 12 | 14 | $1,853 | $1,208 | 65.2% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 29 | 29 | $1,450 | $1,185 | 81.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 19 | 24 | $2,515 | $1,175 | 46.7% |
| 0134A | Adm sarscv2 bvl 50mcg/.5ml a | Office | 2023 | 27 | 27 | $1,350 | $1,103 | 81.7% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 11 | 22 | $1,117 | $767.20 | 68.7% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 11 | 21 | $1,173 | $718.50 | 61.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 38 | 39 | $577.59 | $379.24 | 65.7% |
About Dr. Steven Elliott, M.D
Dr. Steven Elliott, M.D is a Family Medicine healthcare provider based in Carson City, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922061506.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Elliott, M.D has received a total of $5,241 in payments from pharmaceutical and medical device companies, with $320.12 received in 2024. These payments were reported across 369 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($5,204).
As a Medicare-enrolled provider, Elliott has provided services to 10,357 Medicare beneficiaries, totaling 16,260 services with total Medicare billing of $882,358. Data is available for 4 years (2020–2023), covering 113 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Carson City, NV
- Active Since 04/06/2006
- Last Updated 10/07/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1922061506
Products in Payments
- XARELTO (Drug) $319.05
- ANORO (Drug) $226.41
- CHANTIX (Drug) $211.63
- NURTEC ODT (Drug) $194.50
- JARDIANCE (Drug) $191.24
- BREO (Drug) $182.08
- FARXIGA (Drug) $171.29
- Ozempic (Drug) $170.55
- SHINGRIX (Biological) $152.53
- WATCHMAN FLX (Device) $149.96
- Kerendia (Drug) $134.62
- QVAR (Drug) $110.10
- LYRICA (Drug) $107.25
- UBRELVY (Drug) $101.81
- VRAYLAR (Drug) $100.22
- Tresiba (Drug) $98.34
- TRELEGY ELLIPTA (Drug) $94.33
- AJOVY (Drug) $92.63
- ADVAIR (Drug) $87.38
- LINZESS (Drug) $82.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Carson City
Dr. Stuart Stoloff, M.d, M.D
Family Medicine — Payments: $18,869
Dr. Cara-Louise Fox, Md, MD
Family Medicine — Payments: $5,119
Dr. David Johnson, M.d, M.D
Family Medicine — Payments: $4,796
Timothy Gentner, M.d, M.D
Family Medicine — Payments: $4,654
Sarah Maples
Family Medicine — Payments: $4,465
Dr. Mohammad Shahin, Md, MD
Family Medicine — Payments: $1,664